|
|
|
April 2013
Pricing Sheet dated April 25, 2013 relating to Preliminary Terms No. 35 dated April 19, 2013 Registration Statement No. 333-177923 Filed pursuant to Rule 433 |
|
STRUCTURED INVESTMENTS
Opportunities in U.S. Equities
PLUS Based on the Value of the S&P 500® Index due May 7, 2014
Performance Leveraged Upside SecuritiesSM
| PRICING TERMS – APRIL 25, 2013 | ||||||
| Issuer: | JPMorgan Chase & Co. | |||||
| Maturity date: | May 7, 2014, subject to adjustment for certain market disruption events and as described under “Description of PLUS — Payment at Maturity” in the accompanying product supplement no. MS-1-I | |||||
| Underlying index: | S&P 500® Index | |||||
| Aggregate principal amount: | $5,013,000 | |||||
| Payment at maturity: | If the final index value is greater than the initial index value, for each $10 stated principal amount PLUS,
$10 + leveraged upside payment
In no event will the payment at maturity exceed the maximum payment at maturity.
If the final index value is less than or equal to the initial index value, for each $10 stated principal amount PLUS,
$10 × index performance factor
This amount will be less than or equal to the stated principal amount of $10 per PLUS. | |||||
| Leveraged upside payment: | $10 × leverage factor × index percent increase | |||||
| Index percent increase: | (final index value – initial index value) / initial index value | |||||
| Initial index value: | The index closing value of the underlying index on the pricing date, which was 1,585.16 | |||||
| Final index value: | The index closing value of the underlying index on the valuation date | |||||
| Valuation date: | May 2, 2014, subject to adjustment for non-trading days or certain market disruption events and as described under “Description of PLUS — Postponement of a Determination Date” in the accompanying product supplement no. MS-1-I | |||||
| Leverage factor: | 300% | |||||
| Index performance factor: | final index value / initial index value | |||||
| Maximum payment at maturity: | $11.05 (110.50% of the stated principal amount) per PLUS. | |||||
| Stated principal amount: | $10 per PLUS | |||||
| Issue price: | $10 per PLUS (see “Commissions and issue price” below) | |||||
| Pricing date: | April 25, 2013 | |||||
| Original issue date: | April 30, 2013 | |||||
| CUSIP / ISIN: | 48124B428 / US48124B4288 | |||||
| Listing: | The PLUS will not be listed on any securities exchange. | |||||
| Agent: | J.P. Morgan Securities LLC (“JPMS”) | |||||
| Commissions and issue price: | Price to Public(1) | Fees and Commissions(2) | Proceeds to Issuer | |||
| Per PLUS |
$10.00 | $0.20 | $9.80 | |||
| Total |
$5,013,000.00 | $100,260.00 | $4,912,740.00 | |||
| (1) | The price to the public includes the estimated cost of hedging our obligations under the PLUS through one or more of our affiliates, which includes our affiliates’ expected cost of providing such hedge as well as the profit our affiliates expect to realize in consideration for assuming the risks inherent in providing such hedge. For additional related information, please see “Use of Proceeds and Hedging” beginning on PS-31 of the accompanying product supplement no. MS-1-I. |
| (2) | JPMS, acting as agent for JPMorgan Chase & Co., received a commission of $0.20 per $10 stated principal amount PLUS and used all of that commission to allow selling concessions to Morgan Stanley Smith Barney LLC. See “Underwriting (Conflicts of Interest)” beginning on page PS-46 of the accompanying product supplement no. MS-1-I. |
The PLUS are not bank deposits and are not insured by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.
YOU SHOULD READ THIS DOCUMENT TOGETHER WITH THE PRELIMINARY TERMS DESCRIBING THE OFFERING, RELATED PRODUCT SUPPLEMENT NO. MS-1-I, UNDERLYING SUPPLEMENT NO. 1-I, PROSPECTUS SUPPLEMENT AND PROSPECTUS, EACH OF WHICH CAN BE ACCESSED VIA THE HYPERLINKS BELOW. PLEASE ALSO SEE “ADDITIONAL INFORMATION ABOUT THE PLUS” AT THE END OF THIS DOCUMENT.
Preliminary terms no. 35 dated April 19, 2013: http://www.sec.gov/Archives/edgar/data/19617/000119312513163114/d526143dfwp1.pdf
Product supplement no. MS-1-I dated November 22, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007774/e46120_424b2.pdf
Underlying supplement no. 1-I dated November 14, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007615/e46154_424b2.pdf
Prospectus supplement dated November 14, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007578/e46180_424b2.pdf
Prospectus dated November 14, 2011: http://www.sec.gov/Archives/edgar/data/19617/000089109211007568/e46179_424b2.pdf
The issuer has filed a registration statement (including a prospectus) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in this offering will arrange to send you the prospectus if you request it by calling toll-free (800) 869-3326.